Single-use Bioprocessing Market Size, Share, Trends & Forecast, 2026-2034
REPORT DETAILS
Single-use Bioprocessing Market Overview
The global single-use bioprocessing market was valued at USD 18.26 billion in 2025 and is projected to reach USD 57.3 billion by 2034, expanding at a CAGR of 13.50% from 2026 to 2034. Media bags & containers led the product segment with a 31.8% share in 2025, while upstream bioprocessing accounted for 57.6% of the workflow segment. Lower capital investments and reduced cross-contamination risks are a few of the key factors driving market growth.
Market Statistics
Single-use Bioprocessing Market Key Takeaways: Segment Shares, Regional Growth & CAGR
- North America accounted for a 41.7% market share in 2025. This is because of the positive regulatory environment in the region.
- Asia Pacific is projected to grow at a 14.1% CAGR. A surge in biomanufacturing activities in emerging economies drives the regional market growth.
- The media bags & containers segment led with a 31.8% share in 2025. These products are vital for storing biological materials in the biopharmaceutical industry.
- The upstream bioprocessing segment accounted for a 57.6% share in 2025. This is because disposable technologies heavily streamline critical early-stage workflows.
- The biopharmaceutical manufacturers segment led with a 64.3% share in 2025. The segment’s leading position is due to its faster facility setup times.
Note: Figures and projections outlined in this report are the result of Polaris Market Research’s proprietary analytical processes, grounded in the latest available datasets and market observations.
What Is Single-use Bioprocessing? Definition, Components & Benefits
The single-use bioprocessing system involves utilizing disposable rather than reusable equipment made of stainless steel to make biologic drugs. The equipment, including bioreactors, bags, filters, and tubes, is used once and disposed of. It minimizes the time needed for cleaning, reduces the chances of contamination, and helps increase the efficiency of the process.
How Does Single-use Bioprocessing Work? From Cell Culture to Product Recovery
Systems Setup – Pre-sterilized disposable components are installed before initiating production.
Cell Cultivation – Cells are cultivated using single-use bioreactors.
Transfer of Materials – Disposable bags and tubing are used to transfer materials within the process.
Filtration and Purification – Filtration occurs to remove contaminants, aiding purification of the biologic product.
Process Monitoring – Sensors continuously monitor temperature, pH, and other conditions during production.
Product Recovery – Final biologic product is recovered after upstream and downstream processing.
Component Disposal – Disposable components that have been used are discarded safely.
Single-use Bioprocessing Market Overview: Adoption, Scalability & Cost Advantages
Flexibility and scalability are pivotal drivers fueling the expansion of the single-use bioprocessing market share. Single-use systems provide unparalleled flexibility, enabling swift adjustments to production processes and accommodating smaller batches. Their scalability facilitates a seamless transition from laboratory to commercial-scale manufacturing. Biopharmaceutical companies benefit from the capacity to scale production based on market demands, enhancing operational efficiency. Additionally, single-use bioprocessing minimizes the risk of cross-contamination, ensuring product integrity.
In addition, companies operating in the market are introducing new products to expand market reach and strengthen their presence.
- For instance, in May 2026, Thermo Fisher Scientific Inc. introduced the Gibco CTS DynaXS Single Use Bioreactor platform. The company stated that the platform has been developed to help cell therapy developers scale manufacturing with precise control and regulatory readiness.(source: businesswire.com)
Robust regulatory support, notably from agencies like the FDA, propels the growth of the single-use bioprocessing market trends. Guidelines ensure product safety and quality, fostering widespread adoption of single-use technologies. International standards harmonize practices globally, facilitating seamless integration. Essential components like validation processes, risk mitigation, and responsive frameworks for emerging technologies contribute to industry evolution.
Source: Polaris Market Research Analysis
To Understand More About this Research: Download Sample Report
AI in Single-use Bioprocessing: Process Monitoring, Predictive Analytics & Automation
- AI is used in monitoring the data collected from single-use sensors and bioreactors. Through this, it becomes easy for manufacturers to track the key conditions and produce quality products.
- It analyzes a large volume of bioprocess data in order to provide better operating conditions. This results in improved efficiencies in the production process and an increase in product yield and process efficiency.
- AI enables the identification of possible process problems that could lead to problems in product quality or failure of batches. This allows manufacturers to act quickly to save on costs and delays in the manufacturing process.
- AI is contributing towards making single-use bioprocessing more automated and easier to manage.
Single-use vs. Stainless-Steel Bioprocessing: Cost, Contamination Risk & Scalability
| Feature | Single-Use Bioprocessing | Stainless-Steel Bioprocessing |
| Equipment | Disposable equipment | Stainless-steel equipment from the bioprocessing equipment market that can be reused |
| Cleaning | No need for cleaning post processing | Needs cleaning post every batch |
| Risk of Contamination | Less since there are disposable items | May be high if the cleaning process is not done properly |
| Setup Time | Speedy installation and production | Takes more time due to cleaning and validation process |
| Versatility | Can be easily switched from one product to another | Less versatile than single-use bioprocessing |
| Suited for | Small to medium scale production and flexible manufacturing | Large scale and continuous manufacturing |
Source: Polaris Market Research Analysis
Single-use Bioprocessing Market Dynamics
Driver: Expanding Biologics and Biopharmaceutical Manufacturing
The rapid expansion of biopharmaceuticals has spurred the single-use bioprocessing market's growth. Essential in treating diseases, biopharmaceuticals demand flexible and efficient production solutions. Traditional stainless-steel systems face limitations, driving the adoption of single-use technologies. These systems offer versatility, reducing cross-contamination risks, streamlining processes, and requiring lower capital investments. The flexibility of single-use systems allows quick scale-up, catering to changing production demands and enabling swift responses to market needs.
Driver: Rising Biomanufacturing Outsourcing and CDMO Adoption
The surge in biomanufacturing outsourcing is fueling the rapid expansion of the market. Biopharmaceutical firms increasingly opt for outsourcing to enhance efficiency, reduce costs, and expedite production. Single-use bioprocessing technologies offer a flexible, cost-effective solution by eliminating the complexities associated with traditional stainless-steel systems. Outsourcing allows companies to tap into the specialized expertise of contract development and manufacturing organizations (CDMOs), promoting innovation and production streamlining. The scalability of single-use systems aligns with the variable manufacturing demands of outsourcing partners, propelling the growth of the single-use bioprocessing market size and fostering advancements in biomanufacturing capabilities.
Opportunity: Single-use Systems for Cell & Gene Therapy Manufacturing
Single-use bioprocessing is significant for the cell and gene therapy manufacturing market as it allows small and customized production batches. With disposable bioprocessing, there is less time required for setup as well as reduced contamination risk from run-to-run. In addition, it allows faster manufacturing processes and is useful for patient-specific treatments. Single-use technologies in bioprocessing are being adopted by several biotech firms to facilitate ease in the manufacturing process. It is scalable and helps in reducing facility costs. With increased adoption of advanced treatment therapies, single-use bioprocessing is becoming increasingly relevant.
Opportunity: Personalized Medicine and Small-Batch Biomanufacturing
The shift towards personalized medicine necessitates manufacturing processes capable of producing smaller batches of biological medicines. The use of disposable bioprocessing is particularly appropriate in such cases since the disposable systems can easily be prepared for various products without requiring much cleaning. This makes the preparation of patient-specific medicines easier for manufacturers. It also reduces the production time and operating costs while ensuring the quality of the products. With the increase in personalized medicine treatments, such as cell and gene therapy, the use of disposable bioprocessing market systems is expected to grow.
Source: Polaris Market Research Analysis
Restraints: Regulatory Validation, Extractables & Leachables Concerns
Regulatory concerns present a significant hurdle to the expansion of the single-use bioprocessing market report. Despite the advantages of flexibility and cost-effectiveness, regulatory bodies express reservations about integrating these technologies into crucial biopharmaceutical manufacturing processes. Rigorous regulatory scrutiny is essential for adherence to stringent quality standards. The need for standardized guidelines for evaluating single-use systems further complicates the regulatory landscape, necessitating collaborative efforts to establish universally accepted frameworks. Overcoming these concerns requires collaboration between industry stakeholders and regulatory bodies to ensure a regulatory environment supportive of the sustained growth of single-use bioprocessing technologies.
Challenges: Automation, Smart Sensors & Digital Bioprocessing
Automation has increased efficiency in single-use bioprocessing by eliminating the need for manual handling in the production process. Modern bioreactors have sensors to measure temperature, pH levels, pressure, and oxygen dissolution. Digital monitoring platforms allow the manufacturer to monitor the production process and react to any changes in production quickly. AI and data analytics are other technologies that have been used in improving productivity and quality of the products. With the increasing use of digital manufacturing, automation will be an important part of single-use biomanufacturing.
Single-use Bioprocessing Market Segmentation Analysis
The single-use bioprocessing market analysis is primarily segmented based on product, workflow, end user, and region.
| By Product | By Workflow | By End User | By Region |
|
|
|
|
Source: Polaris Market Research Analysis
Single-use Bioprocessing Market by Product: Bags, Filtration, Bioreactors & Mixers
The media bags & containers segment led with a 31.8% share in 2025. Essential in single-use bioprocessing, media bags, and containers are sterile, disposable solutions vital for storing and transporting biological materials in the biopharmaceutical industry. Specifically designed for aseptic environments, these containers facilitate cell cultivation, fermentation, and the storage of media and buffers. Media bags, suitable for various volumes, streamline workflows with their flexibility and scalability, eliminating the need for cleaning and reducing cross-contamination risks. Containers, available in different forms, meet diverse storage needs, ensuring compatibility with a range of biopharmaceutical processes while maintaining crucial sterile conditions.
Single-use Bioprocessing Market by Workflow: Upstream, Downstream & Fermentation
The upstream bioprocessing segment accounted for a 57.6% share in 2025. In biopharmaceutical production, upstream bioprocessing encompasses vital stages like cell culture and fermentation. Adopting single-use technologies in this phase yields flexibility, efficiency, and cost-effectiveness. Disposable bioreactors, bags, and tubing systems create a sterile environment, eliminating the need for cleaning between batches and expediting production. The scalability of single-use systems seamlessly transitions from small-scale research to large-scale manufacturing, meeting diverse production needs. This approach aligns with the trend toward personalized medicine, accommodating smaller batches and reducing capital investments, making it especially attractive for emerging biopharmaceutical companies while responding rapidly to market demands.
Single-use Bioprocessing Market by End User: Biopharma Manufacturers & Research Institutes
The biopharmaceutical manufacturers segment led with a 64.3% share in 2025. Leading biopharmaceutical manufacturers strategically implement single-use bioprocessing to optimize production efficiency. This approach spans cell culture to formulation, offering flexibility for dynamic production adjustments. The use of disposable bioreactors, bags, and tubing eliminates cleaning and validation needs, reducing cross-contamination risks and expediting production timelines. Aligned with industry trends, single-use bioprocessing supports flexible and modular manufacturing, which is especially advantageous for smaller batches and personalized medicines. These technologies are leveraged to enhance efficiency, cut costs, and adapt to the evolving biopharmaceutical landscape.
Single-use Bioprocessing Use Cases: mAbs, Vaccines, Cell & Gene Therapy, Biosimilars
| Application | Description |
| Manufacturing Monoclonal Antibodies | Aids in efficient manufacturing of therapeutic antibodies for different ailments. |
| Production of Vaccines | Makes possible fast and adaptable manufacturing of vaccines. |
| Cell and Gene Therapy | Aids in small batch manufacturing of personalized treatment therapies. |
| Manufacturing of Biosimilars | Assists in making biosimilar medicines efficiently and economically. |
| Personalized Medicine | Makes possible flexible manufacturing of customized biologics. |
| Research and Development | Used for pilot scale and clinical manufacturing in the biopharmaceutical manufacturing market. |
Source: Polaris Market Research Analysis
Source: Polaris Market Research Analysis
Single-use Bioprocessing Sustainability: Plastic Waste, Recycling & Circularity
While single-use systems increase production efficiency, they produce waste in the form of plastics. To help minimize the effects of this, manufacturers are adopting recycling initiatives and improved waste disposal techniques. In addition, they are creating innovative materials that have minimal effect on the environment without reducing the quality of products. Manufacturers are collaborating with waste management companies to enhance the disposal of bioprocessing products. As more emphasis is placed on sustainability, environmentally sustainable manufacturing practices will be increasingly adopted.
Single-use Bioprocessing Market by Region
Asia-Pacific is expected to experience significant growth during the forecast period
Asia Pacific is projected to grow at a 14.1% CAGR. The Asia-Pacific single-use bioprocessing industry is rapidly advancing. Countries like China, India, Japan, and South Korea are witnessing a surge in biomanufacturing activities driven by the cost-effectiveness and scalability of single-use technologies. These advancements align with the region's emphasis on efficiency and affordability.
North America accounted for a 41.7% market share in 2025. With well-established R&D activities and a favorable regulatory landscape, North America holds a significant share globally. Biopharmaceutical companies are increasingly opting for single-use bioprocessing systems, including disposable bioreactors and tubing, to enhance efficiency and flexibility. The region's focus on innovation and evolving bioprocessing techniques aligns with market expansion. As the industry shifts towards personalized medicine and smaller batch production, the continued adoption of single-use systems is anticipated, ensuring cost-effectiveness and compliance with stringent regulatory standards.
Source: Polaris Market Research Analysis
Single-use Bioprocessing Competitive Landscape & Leading Suppliers
The single-use bioprocessing market players encompasses a varied range of participants, and the anticipated influx of new entrants is set to heighten competitive dynamics. Key players in the market consistently refine their technologies, aiming to sustain a competitive edge through a focus on efficiency, dependability, and safety. These entities prioritize strategic initiatives, such as forging alliances, enhancing product portfolios, and engaging in collaborative ventures. Their main objective is to surpass industry rivals, ultimately securing a notable single-use bioprocessing market share.
Leading Single-use Bioprocessing Companies
- Applikon Biotechnology
- Avantor, Inc.
- Boehringer Ingelheim
- Celltainer Biotech BV
- Cesco Bioengineering Co., Ltd.
- Corning Incorporated
- Danaher Corporation
- Eppendorf AG
- Kühner AG
- Lonza Group
- Meissner Filtration Products
- Merck KGaA
- PBS Biotech
- Sartorius AG
- Thermo Fisher Scientific
Single-use Bioprocessing Market Recent Developments & Product Launches
- June 2026: Distek, Inc. announced the release of its software platform, BIOne Core Software. The company stated that the software platform is designed exclusively for BIOne Bioprocess Controllers. It enables easy visualization and management of critical bioprocess data.(source: distekinc.com)
- December 2025: PBS Biotech unveiled its multi-parallel Vertical-Wheel bioreactor platform, MiniPRO. The company stated that the platform has been developed to support high-throughput cell therapy process development in order to optimize and scale-up manufacturing processes.(source: prnewswire.com)
- In June 2025, Sphere Bio expanded its presence in China by entering into a distribution partnership with Redbert Biotechnology to commercialize its picodroplet microfluidics solutions for single-cell analysis.
Single-use Bioprocessing Market Outlook: Automation, Advanced Therapies & Sustainable Systems
The single-use bioprocessing market is expected to register steady growth owing to the growing production of biologicals, vaccines, and advanced therapies. The demand for flexibility and speed in production will drive the use of single-use technology. Automation and digitization of the manufacturing process have improved efficiency and quality of the final product. Single-use products that are more sustainable have also been introduced to mitigate the environmental impact. With advancements in biopharmaceutical manufacturing, single-use bioprocessing is expected to be crucial for modern manufacturing plants.
Single-use Bioprocessing Market Report Coverage
The single-use bioprocessing market report emphasizes on key regions across the globe to provide better understanding of the product to the users. Also, the report provides market insights into recent developments, trends and analyzes the technologies that are gaining traction around the globe. Furthermore, the report covers in-depth qualitative analysis pertaining to various paradigm shifts associated with the transformation of these solutions.
The report provides detailed analysis of the market while focusing on various key aspects such as competitive analysis, products, workflows, end users, and their futuristic growth opportunities.
Single-use Bioprocessing Market Report Scope, Segmentation & Forecast Coverage
| Report Attributes | Details |
| Market size value in 2025 | USD 18.26 billion |
| Market size value in 2026 | USD 20.67 billion |
| Revenue forecast in 2034 | USD 57.3 billion |
| CAGR | 13.50% from 2026 – 2034 |
| Base year | 2025 |
| Historical data | 2021 – 2024 |
| Forecast period | 2026 – 2034 |
| Quantitative units | Revenue in USD billion and CAGR from 2026 to 2034 |
| Segments covered |
|
| Regional scope |
|
| Competitive Landscape |
|
| Report Format |
|
| Customization | Report customization as per your requirements with respect to countries, region and segmentation. |
Source: Polaris Market Research Analysis
Single-use Bioprocessing Market FAQ's
The global Single-use Bioprocessing market size is expected to reach USD 57.3 billion by 2034
Key players in the market are Applikon Biotechnology, Avantor, Inc., Corning Incorporated, Danaher Corporation, Lonza Group
Asia Pacific is a region contributing notably to the global Single-use Bioprocessing Market, projected to grow at a 14.1% CAGR, driven by a surge in biomanufacturing activities in emerging economies.
Single-use Bioprocessing Market exhibiting the CAGR of 13.50% during the forecast period.
One of the key segments is media bags & containers, which led the market with a 31.8% share in 2025. These products are vital for storing biological materials in the biopharmaceutical industry.
Single-use bioprocessing is defined as a manufacturing process that uses single-use equipment such as bioreactors, bags, filters, and tubing to manufacture biologic products.
Disposable bioreactors refer to single-use bioreactors that are employed in cultivating cells in the manufacture of biopharmaceuticals. They help reduce cleaning and sterilization and make faster production possible.
Various benefits come with the use of single-use bioprocessing techniques. Some of them include decreased risk of contamination, increased production speed, and flexibility during production.
Download Sample Report of Single-use Bioprocessing Market
Please fill out the form to request a customized copy of the research report.
